Dr Reddy's launches halometasone in India
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories has launched halometasone cream 0.05% (marketed as Execare) in India. The product is used in the treatment of acute/chronic steroid responsive dermatoses and vitiligo. Execare is a potent steroid and recommended as an alternative to betamethasone dipropionate and mometasone furoate. The Indian market for topical steroids was estimated at about Rs1.20 billion ($24.7 million) for the 12 months ended May 2009 and reported 14% growth.